Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels
- PMID: 24632496
- DOI: 10.1016/j.arr.2014.02.007
Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels
Abstract
While sarcopenia and sarcopenic obesity have been recognized in the last decade, a combined concept to include decreased muscle mass and strength, as well as decreased bone mass with coexistence of adiposity is discussed here. We introduce a new term, osteopenic obesity, and operationalize its meaning within the context of osteopenia and obesity. Next, we consolidate osteopenic obesity with the already existing and more familiar term, sarcopenic obesity, and delineate the resulting combined condition assigning it the term osteosarcopenic obesity. Identification and possible diagnosis of each condition are discussed, as well as the interactions of muscle, fat and bone tissues on cellular level, considering their endocrine features. Special emphasis is placed on the mesenchymal stem cell commitment into osteoblastogenic, adipogenic and myogenic lineages and causes of its deregulation. Based on the presented evidence and as expounded within the text, it is reasonable to say that under certain conditions, osteoporosis and sarcopenia could be the obesity of bone and muscle, respectively, with the term osteosarcopenic obesity as an encompassment for all.
Keywords: Inflammation; Mesenchymal stem cells; Osteopenic obesity; Osteosarcopenic obesity; Sarcopenia.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Understanding the Consequences of Fatty Bone and Fatty Muscle: How the Osteosarcopenic Adiposity Phenotype Uncovers the Deterioration of Body Composition.Metabolites. 2023 Oct 7;13(10):1056. doi: 10.3390/metabo13101056. Metabolites. 2023. PMID: 37887382 Free PMC article. Review.
-
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.Calcif Tissue Int. 2019 Aug;105(2):109-124. doi: 10.1007/s00223-019-00561-w. Epub 2019 May 16. Calcif Tissue Int. 2019. PMID: 31098729 Review.
-
Adipose, bone and muscle tissues as new endocrine organs: role of reciprocal regulation for osteoporosis and obesity development.Horm Mol Biol Clin Investig. 2014 Jan;17(1):39-51. doi: 10.1515/hmbci-2013-0070. Horm Mol Biol Clin Investig. 2014. PMID: 25372729 Review.
-
Osteosarcopenic Obesity Syndrome: What Is It and How Can It Be Identified and Diagnosed?Curr Gerontol Geriatr Res. 2016;2016:7325973. doi: 10.1155/2016/7325973. Epub 2016 Sep 7. Curr Gerontol Geriatr Res. 2016. PMID: 27667996 Free PMC article. Review.
-
Endocrinology of adipose tissue - an update.Horm Metab Res. 2007 May;39(5):314-21. doi: 10.1055/s-2007-976539. Horm Metab Res. 2007. PMID: 17533572 Review.
Cited by
-
Fat as a Friend or Foe of the Bone.Curr Osteoporos Rep. 2024 Feb 28. doi: 10.1007/s11914-024-00864-4. Online ahead of print. Curr Osteoporos Rep. 2024. PMID: 38416274 Review.
-
The Current Landscape of Pharmacotherapies for Sarcopenia.Drugs Aging. 2024 Feb;41(2):83-112. doi: 10.1007/s40266-023-01093-7. Epub 2024 Feb 5. Drugs Aging. 2024. PMID: 38315328
-
A comprehensive meta-analysis of risk factors associated with osteosarcopenic obesity: a closer look at gender, lifestyle and comorbidities.Osteoporos Int. 2024 Jan 15. doi: 10.1007/s00198-023-07007-y. Online ahead of print. Osteoporos Int. 2024. PMID: 38224388 Review.
-
Individual and combined associations of sarcopenia, osteoporosis and obesity with frailty in a multi-ethnic asian older adult population.BMC Geriatr. 2023 Dec 5;23(1):802. doi: 10.1186/s12877-023-04500-1. BMC Geriatr. 2023. PMID: 38053025 Free PMC article.
-
Discovering the Individualized Factors Associated with Sarcopenia and Sarcopenic Obesity Phenotypes-A Machine Learning Approach.Nutrients. 2023 Oct 26;15(21):4536. doi: 10.3390/nu15214536. Nutrients. 2023. PMID: 37960189 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
